Company intelligence
NeuroDex
Blood-Based Biomarkers for Neurodegenerative Diseases
Biotechnology Research
Natick, US
16 employees
Founded 2018
1 public signals
About NeuroDex
NeuroDex develops blood-based diagnostics for neurodegenerative disease using neuron-derived exosomes (NDEs). Our ExoSORT™ and LuminEV platforms support biomarker discovery, clinical trial validation, and translational research for ALS, Parkinson's, Alzheimer's, and Lewy Body Dementia. We partner with pharma and biotech to bring precision biomarkers into clinical development.
Verified activity
Signals from NeuroDex
1 published signal